KNUDSEN STEEN enters ALLARITY THERAPEUTICS, INC. with 124.98K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/22/2021ACC: 0001213900-21-067037
Officer· Chief Scientific Officer
Since Dec 2021
124.98K
Baseline shares
1% direct
1.60K
Direct ownership
1 position
78.33K
Derivative underlying
1 instrument
2
Security positions
123.37K indirect
Non-Derivative Holdings2
Common Stock, $0.0001
DirectShares owned1.60K
Common Stock, $0.0001
IndirectShares owned123.37K
Total
1.60K direct·123.37K indirect124.98K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 | 1.60K | Direct |
| Common Stock, $0.0001 | 123.37K | Indirect |
| Total | 124.98K | 1.60K direct·123.37K indirect |
Derivative Holdings1
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
78.33K
Shares owned
N/A
Exercise price
5.16
Expiration
—
Exercise window
—
Total
Underlying
78.33K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 5.16 | — | — | 78.33K | N/A |
| Total | 78.33K | 0.00 | ||||